Practical Considerations in Convalescent Plasma Therapy for Coronavirus Disease 2019

J. Roh, Hyun Mi Kim, Jun Nyun Kim, Sinyoung Kim, H. Kim
{"title":"Practical Considerations in Convalescent Plasma Therapy for Coronavirus Disease 2019","authors":"J. Roh, Hyun Mi Kim, Jun Nyun Kim, Sinyoung Kim, H. Kim","doi":"10.17945/kjbt.2020.31.1.67","DOIUrl":null,"url":null,"abstract":"Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Korean Journal of Blood Transfusion","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17945/kjbt.2020.31.1.67","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine
2019冠状病毒病恢复期血浆治疗的实践思考
恢复期血浆治疗已被用于通过给药病原体特异性抗体来实现对多种感染因子的被动免疫,该病毒起源于中国武汉。由于缺乏对这种病毒的认识和证据,目前还没有针对COVID-19的具体治疗建议,恢复期血浆治疗可以作为COVID-19的经验性和研究性治疗,因此我们从输血医学的角度简要介绍恢复期血浆治疗相关的主要问题
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信